Centiva Capital, LP Eli Lilly & CO Call Options Transaction History

Centiva Capital, LP

$4.79 Billion
Q3 2024

Call Options

20 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$772.14 - $960.02 $154,428 - $192,004	200 Added 15.38%	1,500 $1.33 Million
Q2 2024 Aug 14, 2024	SELL	$724.87 - $909.04 $3.41 Million - $4.27 Million	-4,700 Reduced 78.33%	1,300 $1.18 Million
Q1 2024 May 15, 2024	BUY	$592.2 - $792.28 $1.78 Million - $2.38 Million	3,000 Added 100.0%	6,000 $4.67 Million
Q4 2023 Feb 14, 2024	SELL	$525.19 - $619.13 $4.78 Million - $5.63 Million	-9,100 Reduced 75.21%	3,000 $1.75 Million
Q3 2023 Nov 14, 2023	BUY	$434.7 - $599.3 $4.35 Million - $5.99 Million	10,000 Added 476.19%	12,100 $6.5 Million
Q2 2023 Aug 14, 2023	SELL	$350.74 - $468.98 $1.05 Million - $1.41 Million	-3,000 Reduced 58.82%	2,100 $984,000
Q1 2023 May 15, 2023	SELL	$310.63 - $364.82 $8.2 Million - $9.63 Million	-26,400 Reduced 83.81%	5,100 $1.75 Million
Q4 2022 Feb 14, 2023	BUY	$321.55 - $374.67 $1.09 Million - $1.27 Million	3,400 Added 12.1%	31,500 $11.5 Million
Q3 2022 Nov 14, 2022	BUY	$296.48 - $337.87 $5.37 Million - $6.12 Million	18,100 Added 181.0%	28,100 $9.09 Million
Q2 2022 Aug 17, 2022	SELL	$278.73 - $327.27 $4.74 Million - $5.56 Million	-17,000 Reduced 62.96%	10,000 $3.24 Million
Q1 2022 May 16, 2022	SELL	$234.69 - $291.66 $20.3 Million - $25.3 Million	-86,700 Reduced 76.25%	27,000 $7.73 Million
Q4 2021 Feb 14, 2022	BUY	$224.85 - $279.04 $23.3 Million - $29 Million	103,800 Added 1048.48%	113,700 $31.4 Million
Q2 2020 Aug 14, 2020	SELL	$136.42 - $164.18 $1.64 Million - $1.97 Million	-12,000 Reduced 54.79%	9,900 $1.63 Million
Q1 2020 May 15, 2020	BUY	$119.05 - $147.35 $1.63 Million - $2.02 Million	13,700 Added 167.07%	21,900 $3.03 Million
Q4 2019 Feb 14, 2020	BUY	$106.92 - $132.43 $416,988 - $516,477	3,900 Added 90.7%	8,200 $1.08 Million
Q2 2019 Aug 13, 2019	SELL	$110.79 - $129.32 $3.33 Million - $3.89 Million	-30,100 Reduced 87.5%	4,300 $476,000
Q1 2019 May 14, 2019	SELL	$111.31 - $131.02 $2.32 Million - $2.73 Million	-20,800 Reduced 37.68%	34,400 $4.46 Million
Q4 2018 Feb 13, 2019	BUY	$105.9 - $118.64 $1.75 Million - $1.96 Million	16,500 Added 42.64%	55,200 $6.39 Million
Q3 2018 Nov 14, 2018	BUY	$85.86 - $107.31 $995,976 - $1.24 Million	11,600 Added 42.8%	38,700 $4.15 Million
Q2 2018 Aug 03, 2018	BUY	$75.7 - $86.88 $2.05 Million - $2.35 Million	27,100 New	27,100 $2.31 Million

Others Institutions Holding LLY

# of Institutions

3,994

Shares Held

752M

Call Options Held

7.31M

Put Options Held

9.23M

Lilly Endowment Inc Indianapolis, IN

96.9M
Shares

$76.2 Billion
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

73.8M
Shares

$58 Billion
1.2% of portfolio
Black Rock Inc. New York, NY

65.9M
Shares

$51.8 Billion
1.37% of portfolio
Pnc Financial Services Group, Inc. Pittsburgh, PA

51.4M
Shares

$40.4 Billion
29.2% of portfolio
State Street Corp Boston, MA

33.9M
Shares

$26.6 Billion
1.24% of portfolio

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $747B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Centiva Capital, LP, based on Form 13F filings with the SEC.

News

Stay updated on Centiva Capital, LP with notifications on news.

Account